Skip to main content
. 2019 Mar 12;10:481. doi: 10.3389/fimmu.2019.00481

Figure 6.

Figure 6

Antibody-induced antitumor immunity can be enhanced by modulation of antibody: FcγR interactions. Left panel (no antibody checkpoint modulation). Antibody efficacy is balanced by co-engagement of activating and inhibitory FcγR. Center panel (enhanced engagement of activating FcγR). Antibody efficacy is improved through Fc-engineering for enhanced binding to activating FcγR. Right panel–Antibody efficacy is enhanced by blockade of the inhibitory FcγRIIB.